Neurocrine Biosciences (NBIX) Non Operating Income (2009 - 2026)
Neurocrine Biosciences (NBIX) recorded Non Operating Income of -$47.6 million in Q3 2026, compared with $52.8 million a year earlier.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Non Operating Income (2009 - 2026) Analysis & Trends
On a TTM basis, Neurocrine Biosciences' Non Operating Income came in at $45 million as of Sep 30, 2026, down 42.6% year-over-year; for FY2025, it was $86.3 million.
- Across earlier years, Non Operating Income came in at -$84.5 million in FY2024, $81.2 million in FY2023, -$35.1 million in FY2022 and -$1.1 million in FY2021.
- The Q3 2026 figure is the lowest quarterly Non Operating Income since Q1 2024.
- On a year-over-year basis, Non Operating Income rose in two of the last four quarters, with growth averaging 167.7%.
- Per Business Quant, the preceding three quarters came in at $10.7 million (Q2 2026), $53.4 million (Q1 2026) and $28.5 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | -47.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -47.60 Mn |
| Jun 30, 2026 | 10.70 Mn |
| Mar 31, 2026 | 53.40 Mn |
| Dec 31, 2025 | 28.50 Mn |
| Sep 30, 2025 | 52.80 Mn |
| Jun 30, 2025 | 13.90 Mn |
| Mar 31, 2025 | -8.90 Mn |
| Dec 31, 2024 | 20.60 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | -46.80 Mn |
| Mar 31, 2024 | -64.80 Mn |
| Dec 31, 2023 | 47.90 Mn |
| Sep 30, 2023 | -25.60 Mn |
| Jun 30, 2023 | 48.00 Mn |
| Mar 31, 2023 | 10.90 Mn |
| Dec 31, 2022 | 14.50 Mn |
| Sep 30, 2022 | 10.10 Mn |
| Jun 30, 2022 | -78.00 Mn |
| Mar 31, 2022 | 18.30 Mn |
| Dec 31, 2021 | 22.50 Mn |
API Access
Neurocrine Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();